Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2018 08:00 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif, Feb. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
February 05, 2018 09:00 ET | Source: CareDx, Inc.

CareDx Leadership in cfDNA Highlighted at CEoT

BRISBANE, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically...
February 01, 2018 08:00 ET | Source: CareDx, Inc.

First Patient Enrolled in AlloSure Registry

BRISBANE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
January 16, 2018 09:00 ET | Source: CareDx, Inc.

TRIO Honors Peter Maag with Transplant Innovation Award

BRISBANE, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically...
January 08, 2018 08:30 ET | Source: CareDx, Inc.

CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results

BRISBANE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 20, 2017 08:00 ET | Source: CareDx, Inc.

CMS Releases 2018 Clinical Laboratory Fee Schedule

BRISBANE, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 15, 2017 09:00 ET | Source: CareDx, Inc.

CareDx Further Simplifies its Balance Sheet

BRISBANE, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 09, 2017 16:02 ET | Source: CareDx, Inc.

CareDx Reports Third Quarter 2017 Financial Results

BRISBANE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 02, 2017 09:00 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 31, 2017 09:00 ET | Source: CareDx, Inc.

CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRISBANE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...